Friday broker round-up UPDATE
14th Feb 2014 10:26
Assura Group: Liberum Capital shifts target price from 44p to 44.40p and retains a buy recommendation. Barclays: Credit Suisse lowers target price from 270p to 260p and keeps a neutral rating. Bellway: Panmure Gordon raises target price from 1520p to 1639p and maintains a buy recommendation. UBS i
Read moreHikma Pharmaceuticals to deliver higher than expected FY revenue
14th Feb 2014 08:04
Hikma Pharmaceuticals on Friday reported a strong performance by its Injectables business ahead of the release of its 2013 results next month, which it said would now show a higher-than-expected revenue increase. The group said revenue for the 12-month period would now be around 23% above the prior
Read moreWednesday broker round-up UPDATE
27th Nov 2013 09:14
Aviva: Nomura moves target price from 474p to 489p retaining a buy recommendation. Bellway: Numis upgrades to buy with a target price of 1690p. Breedon Aggregates: Jefferies starts with a target price of 42p and a buy recommendation. Britvic: UBS ups target price from 575p to 600p and keeps a neu
Read moreHikma signs syringe supply deal with Unilife Corp
20th Nov 2013 07:08
Pharmaceuticals group Hikma has signed a 15-year commercial supply deal with US firm Unilife Corporation for the use of its Unifill prefilled syringes. Pennsylvania-based Unilife will supply Hikma with customised prefillable syringes to be used with a range of the FTSE 250 group's generic injectabl
Read moreCarillion Finance Director lowers holding
8th Nov 2013 16:03
Carillion's Group Finance Director, Richard Adam, on Thursday sold, on behalf of his wife, 40,000 shares. Each of these was sold for 309.04p, for a total trade value of £123,616. Adam's stake now stands at 118,238 shares. The disposal was made a week after the support services company announced
Read moreFriday broker round-up UPDATE
8th Nov 2013 09:21
Abcam: Canaccord Genuity moves target price from 396p to 386p and keeps a sell recommendation. N+1 Singer shifts target price from 450p to 445p downgrading to sell. Aberdeen Asset Management: Jefferies lowers target price from 440p to 430p and reiterates a hold recommendation. Anglo American: Gold
Read moreHikma Pharmaceuticals expects annual revenue growth
8th Nov 2013 07:45
Hikma Pharmaceuticals said it is maintaining its guidance for 2013 for 20 per cent revenue growth on the back of a strong performance across all its divisions. The group's global Injectables business has delivered robust results, particularly in the US, where growth is being driven by demand acros
Read moreHikma signs joint venture with MIDROC to enter Ethiopian market
18th Sep 2013 07:28
Hikma Pharmaceuticals has signed a joint venture agreement with MIDROC Pharmaceuticals to enter the Ethiopian medicine market. The joint venture, HikmaCure, will establish an Ethiopian operating company, build a local manufacturing facility and begin marketing and distributing pharmaceutical produ
Read moreLondon midday: Markets cautious ahead of risk events, Syria action
4th Sep 2013 11:26
Traders adopted a cautious approach on Wednesday morning with UK stocks registering losses in morning trade ahead of a number of 'risk events' later in the week which have the potential to spark market volatility. Fears about impending US military action in Syria also hit investor sentiment today a
Read moreLondon open: Potential strike on Syria worries investors early on
4th Sep 2013 08:32
Stocks declined on Wednesday morning on concerns over an imminent Western military intervention in Syria, with investors also choosing to scale back positions ahead of a number of 'risk events' later on in the week. The Senate Foreign Relations Committee last night gave the green light on a US atta
Read moreThursday tips round-up: Serco, Hikma Pharmaceuticals, Goals Soccer Centres
22nd Aug 2013 07:31
The future for outsourcing outfit Serco is now uncertain as the Government calls for a detailed review of all contracts and profit margins are expected to slide. However, its update on trading in the second quarter was good. With long-term government contracts comes steady cash flow, and Serco has b
Read moreThursday broker round-up UPDATE
22nd Aug 2013 07:25
Aggreko: RBC Capital reduces target price from 1850p to 1680p, while its neutral rating remains unchanged. Aviva: JP Morgan raises target price from 393p to 436p and retains an overweight rating. BHP Billiton: Canaccord Genuity takes target price from 1950p to 2050p maintaining a hold recommendati
Read moreFTSE 250 movers: N Brown jumps after broker upgrade
21st Aug 2013 14:36
Internet shopping group N Brown was a high riser today after Credit Suisse raised its rating for the stock from 'neutral' to 'outperform' and lifted its target price from 455p to 620p. N Brown, whose brands include Simply Be, Jacamo and Figleaves, has seen its stock surge by around 50% so far this
Read moreLondon midday: Ex-div stocks drag FTSE 100 to six-week low
21st Aug 2013 11:33
Markets were sharply lower on Wednesday morning as risk appetite was scaled back ahead of this evening's release of the minutes of the latest Federal Reserve policy meeting. The FTSE 100 was trading as low as 6,400 today in London today; the last time it closed below this level was on July 5th when
Read moreLondon open: FTSE 100 slips as investors await Fed minutes
21st Aug 2013 08:29
The FTSE 100 fell into the red on Wednesday morning, hitting a fresh six-week low as investors nervously awaited the minutes of the latest Federal Reserve meeting. The index dropped 0.5% to around the 6,420 mark early on. The last time the London benchmark closed lower was on July 5th when it finis
Read more